About
Vivanza Biosciences Limited engages in the manufacturing and sale of pharmaceutical products in India. It offers pharmaceuticals in various categories; injectable products, including antifungals, antibiotics, antivirals, and other products for hospital and clinical use; Vivanza medical gloves for medical and surgical use; therapeutic index injection; and veterinary products and feed. The company was incorporated in 1982 and is headquartered in Ahmedabad, India.
Key Metrics
as of Sep 2026Market Cap7 Cr
P/E15.20
Div Yield0.00 %
Book ValueβΉ1.09
52w HighβΉ2.72
52w LowβΉ1.52
Face ValueβΉ1.00
Quarterly Results
Rs. Crores Β· hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.29 | 6.36 | 45.25 | 55.36 | 8.94 | 0.48 | 1.50 | 3.00 | 2.44 | 4.42 | 6.56 | 7.62 | 9.23 |
| Expenses | 9.36 | 6.59 | 45.04 | 54.75 | 8.79 | 1.44 | 1.37 | 2.89 | 2.08 | 4.56 | 6.27 | 7.30 | 8.64 |
| Operating Profit | -0.07 | -0.23 | 0.21 | 0.61 | 0.15 | -0.96 | 0.13 | 0.11 | 0.36 | -0.14 | 0.29 | 0.32 | 0.59 |
| OPM % | -0.75 | -3.62 | 0.46 | 1.10 | 1.68 | -200.00 | 8.67 | 3.67 | 14.75 | -3.17 | 4.42 | 4.20 | 6.39 |
| Other Income | 0.37 | 0.01 | 0.08 | 0.01 | 0.02 | 0.05 | 0.01 | 0.00 | 0.00 | -0.03 | 0.02 | 0.05 | 0.01 |
| Depreciation | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest | 0.11 | 0.07 | 0.09 | 0.05 | 0.08 | 0.08 | 0.09 | 0.09 | 0.09 | 0.09 | 0.10 | 0.11 | 0.11 |
| Profit before tax | 0.18 | -0.30 | 0.20 | 0.57 | 0.09 | -0.99 | 0.05 | 0.02 | 0.27 | -0.27 | 0.21 | 0.26 | 0.49 |
| Tax % | 22.22 | 50.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 0.00 | 0.00 | 55.56 | 0.00 | 0.00 | 0.00 |
| Net Profit | 0.15 | -0.45 | 0.20 | 0.56 | 0.09 | -1.00 | 0.04 | 0.02 | 0.27 | -0.41 | 0.21 | 0.26 | 0.49 |
| EPS in Rs | 0.04 | -0.11 | 0.05 | 0.14 | 0.02 | -0.25 | 0.01 | 0.00 | 0.07 | -0.10 | 0.05 | 0.06 | 0.12 |
Profit & Loss
Annual Β· Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 116.00 | 7.00 | 28.00 | 18.00 | 10.00 | 10.00 | 10.00 | 3.00 | 6.00 | 3.00 | 0.00 |
| Expenses | 115.00 | 8.00 | 27.00 | 17.00 | 10.00 | 10.00 | 10.00 | 3.00 | 6.00 | 4.00 | 0.00 |
| Operating Profit | 1.00 | 0.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 |
| OPM % | 0.60 | -4.90 | 3.90 | 3.80 | -0.60 | 0.90 | -3.60 | -0.80 | 9.00 | -9.00 | β |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 1.00 | -1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax % | 27.00 | 2.00 | 21.00 | 17.00 | 0.00 | 42.00 | 0.00 | 0.00 | 13.00 | 0.00 | 0.00 |
| Net Profit | 0.00 | -1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS in Rs | 0.10 | -0.17 | 0.14 | 0.15 | 0.08 | 0.02 | -0.05 | -0.11 | 0.05 | -0.08 | -0.32 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual Β· Rs. Crores β latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 0.19 |
| Reserves | 0.00 | 0.00 | 1.00 | 0.00 | -1.00 | -1.00 | -1.00 | -1.00 | 0.00 | 0.00 | 0.00 |
| Borrowings | 10.00 | 9.00 | 5.00 | 8.00 | 6.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 0.00 |
| Other Liabilities | 8.00 | 4.00 | 10.00 | 10.00 | 7.00 | 5.00 | 9.00 | 6.00 | 5.00 | 3.00 | 0.00 |
| Total Liabilities | 22.00 | 16.00 | 20.00 | 22.00 | 16.00 | 8.00 | 12.00 | 11.00 | 10.00 | 7.00 | 1.00 |
| Fixed Assets | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 20.00 | 14.00 | 17.00 | 20.00 | 13.00 | 6.00 | 10.00 | 9.00 | 8.00 | 5.00 | 1.00 |
| Total Assets | 22.00 | 16.00 | 20.00 | 22.00 | 16.00 | 8.00 | 12.00 | 11.00 | 10.00 | 7.00 | 1.00 |
Cash Flows
Annual Β· Rs. Crores β latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -3.00 | -2.00 | 2.00 | -1.00 | 2.00 | -3.00 | 3.00 | 1.00 | 0.00 | -2.00 | 0.00 |
| Cash from Investing Activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 | 0.00 |
| Cash from Financing Activity | 3.00 | 2.00 | -2.00 | 1.00 | -2.00 | 3.00 | -3.00 | -1.00 | -1.00 | 0.00 | 0.00 |
| Net Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.00 | 0.00 | 0.00 |
| Free Cash Flow | -3.00 | -3.00 | 2.00 | -1.00 | 2.00 | -3.00 | 3.00 | 1.00 | 0.00 | -2.00 | 0.00 |
| CFO/OP % | -328.00 | 692.00 | 203.00 | -124.00 | -4,117.00 | -3,367.00 | -876.00 | -4,300.00 | -15.00 | 668.00 | 0.00 |
Ratios
Annual Β· Days / % β latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 39.00 | 398.00 | 151.00 | 256.00 | 275.00 | 231.00 | 250.00 | 782.00 | 287.00 | 267.00 |
| Inventory Days | 11.00 | 121.00 | 28.00 | 55.00 | 92.00 | 26.00 | 38.00 | 309.00 | 150.00 | 215.00 |
| Days Payable | 23.00 | 140.00 | 116.00 | 211.00 | 207.00 | 154.00 | 319.00 | 878.00 | 319.00 | 304.00 |
| Cash Conversion Cycle | 27.00 | 379.00 | 64.00 | 99.00 | 160.00 | 103.00 | -32.00 | 213.00 | 118.00 | 178.00 |
| Working Capital Days | 7.00 | 154.00 | 44.00 | 50.00 | 103.00 | 104.00 | 109.00 | 469.00 | 237.00 | 332.00 |
| ROCE % | 6.00 | -3.00 | 10.00 | 11.00 | 12.00 | 17.00 | 6.00 | 0.00 | 13.00 | -10.00 |
Corporate Actions
2 records| Action | Ex Date | Record Date | Ratio | Amount (βΉ) | Notes |
|---|---|---|---|---|---|
| Split | 24 Mar 2023 | 24 Mar 2023 | 10:1 | β | |
| Other | 27 May 2015 | 28 May 2015 | β | β | Reduction of Capital |